Don't disagree. Some absolute muppets who come on CYP. threads...

Don't disagree. Some absolute muppets who come on CYP. threads from MSB. Sector in his only defence is ganged up upon.

But the trivial arguments of MSBer's vs CYPer's on Hot Copper get in the way of information discovery, which as retail holders we can all benefit from and are disadvantaged on compared to Insto's.

If people think CYP's share price and plight are not somewhat tied into MSB, they've rocks in their heads. The petty repetitive squabbles of idiots dominate these threads. Imagine how positive it would be if they constructively colluded in intelligent debate and insight.

I am mainly invested in CYP because of its Phase III OA study. Its funny, CYP investors could so easily look down on RGS investors, another little Aussie stem cell company that is trying to develop a stem cell treatment for knee OA., mainly in Japan (I actually had successful autologous MSc stem-cell treatment off them years ago, that they no longer offer). I remain invested in it (small). I consider its likely success, far less convincing than CYP in the area. Do I consider those things mutually exclusive? No.

Its share price will likely be buoyed by any success CYP has in its trial, just as CYP will likely be if MSB finally makes some approval headway with the FDA.